AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|
32 C
New York
Tuesday, June 30, 2026

Tag: actions

newssourceFORcompanyinformationcontent1releasesmarket

RON FLEMING APPOINTED CHIEF EXECUTIVE OFFICER OF LAZYDAYS

TAMPA, Fla., July 9, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. (NASDAQCM: GORV) ("Lazydays" or the "Company") announced today that Ron Fleming has been appointed...

IOVA DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July...

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline.

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality...


Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Voltalia SA : Nombre total de droits de vote et d’actions composant le capital en date du 30 juin 2025

Nombre total de droits de vote et d’actions composant le capital en date du 30 juin 2025
(Art. L. 233-8 (II) du Code de Commerce et Art. 223-16 du Règlement Général de l’AMF)

KLÉPIERRE: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL DE KLÉPIERRE SA AU 30 JUIN 2025

COMMUNIQUÉ RÉGLEMENTÉ

Brunswick Corporation Schedules 2025 Second Quarter Earnings Conference Call

METTAWA, Ill., July 09, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2025 second quarter financial results on Thursday, July 24, 2025 before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website at https://ir.brunswick.com.  The results will also be available on the SEC’s website with the Form 8-K filing of the release at http://goo.gl/wJQN1.   

Important Notice to Long-Term Shareholders of CorMedix Inc. (NASDAQ: CRMD); Maison Solutions, Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical...

PHILADELPHIA, July 09, 2025 (GLOBE NEWSWIRE) --

CorMedix Inc. (NASDAQ: CRMD) Shareholder Class Action Survives Motion to Dismiss:

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

ARIS MINING REMINDS ARIS.WT.A WARRANT HOLDERS OF UPCOMING EXPIRY

VANCOUVER, BC, July 9, 2025 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) reminds holders of its TSX-listed warrants...

ARIS MINING REMINDS ARIS.WT.A WARRANT HOLDERS OF UPCOMING EXPIRY

VANCOUVER, BC, July 9, 2025 /CNW/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) reminds holders of its TSX-listed warrants...

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

Alvotech acquires capability and added flexibility in assembly and packaging with acquisition of Ivers-Lee Group

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsActions

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers